Advertisement

Topics

Screening for Neuroendocrine Tumors Is Recommended for NF1 Patients

06:25 EDT 15 Sep 2018 | Cancer Networks

A study on pheochromocytoma and paraganglioma associated with neurofibromatosis type 1 highlights how screening for these malignancies is important.

Original Article: Screening for Neuroendocrine Tumors Is Recommended for NF1 Patients

NEXT ARTICLE

More From BioPortfolio on "Screening for Neuroendocrine Tumors Is Recommended for NF1 Patients"

Advertisement
Quick Search
Advertisement
Advertisement